Home › Biogen Idec And Swedish Orphan Biovitrum Announce European Medicines...
 

Keywords :   


Biogen Idec And Swedish Orphan Biovitrum Announce European Medicines...

2014-11-04 04:36:32| Appliances - Topix.net

CAMBRIDGE, Mass. & STOCKHOLM-- --Biogen Idec and Swedish Orphan Biovitrum AB today announced that the European Medicines Agency has validated the Marketing Authorization Application of ELOCTATM , a recombinant factor VIII Fc fusion protein product candidate for the treatment of hemophilia A. The validation of the MAA initiates the EMA's review process.

Tags: european swedish announce medicines

Category:Consumer Goods and Services

Latest from this category

All news
05.11NI rise hits workers harder than employers, says OBR
05.11Netflix Europe offices raided in tax fraud probe
05.11Vodafone-Three merger could get green light, watchdog says
05.11Altice USA residential video RGUs down 77,000 in 3Q 2024
05.11Shoppers warned over luxury advent calendar scams
05.11Shoplifting levels 'unacceptable', inquiry finds
05.11Green energy plan needs 600 miles of power lines - report
05.11Xumo teams up with Target to offer Hisense Xumo TVs
Consumer Goods and Services »
05.11NI rise hits workers harder than employers, says OBR
05.11Tropical Storm Rafael Graphics
05.11Tropical Storm Rafael Wind Speed Probabilities Number 8
05.11Tropical Storm Rafael Public Advisory Number 8
05.11Summary for Tropical Storm Rafael (AT3/AL182024)
05.11Tropical Storm Rafael Forecast Advisory Number 8
05.11Lenzing Expands Nonwovens Range
05.11Netflix Europe offices raided in tax fraud probe
More »